Your session is about to expire
← Back to Search
Specific Trunk Interventions for Cerebral Palsy
N/A
Recruiting
Led By Ming Wu
Research Sponsored by Shirley Ryan AbilityLab
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, post 6 weeks of training and 8 weeks after the end of training.
Awards & highlights
Study Summary
This trial studies how exercise can help posture & walking in kids with cerebral palsy.
Who is the study for?
This trial is for children aged 4-12 with bilateral spastic cerebral palsy (CP), specifically those who can express discomfort, have mild scoliosis, and haven't had hippotherapy, Botulinum toxin treatment or surgeries like selective dorsal rhizotomy recently. It's not for kids with aggressive behaviors, severe leg issues, unhealed skin lesions on the legs, or serious cardiovascular conditions.Check my eligibility
What is being tested?
The study aims to see if robotic hippotherapy—a type of therapy using robot-assisted horseback riding movements—improves trunk posture and walking functions in children with CP compared to conventional physical therapy.See study design
What are the potential side effects?
While specific side effects are not listed for this intervention, general risks may include discomfort during exercises or potential strain from physical activities involved in both robotic hippotherapy and conventional therapy.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, post 6 weeks of training and 8 weeks after the end of training.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, post 6 weeks of training and 8 weeks after the end of training.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Trunk Control Measurement Scale (TCMS) score from baseline.
Secondary outcome measures
Chang in 6-minute walking distance from baseline
Change in GMFM-66
Change in Walking speed from baseline
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Robotic hippotherapyExperimental Treatment1 Intervention
For the robotic training group, each subject will be trained for 40 minutes. Specifically, each participant will sit astride on a robotic horse with the force perturbation will be applied in the anterior-posterior direction and up/down direction.
Group II: Conventional physical therapyActive Control1 Intervention
For the conventional physical therapy group, each subject will be trained for 40 minutes, which will include 10 minutes of stretching, followed by 10 minutes of sitting and 10 minutes of standing balance training, and 10 minutes of treadmill walking.
Find a Location
Who is running the clinical trial?
Shirley Ryan AbilityLabLead Sponsor
194 Previous Clinical Trials
16,868 Total Patients Enrolled
Ming WuPrincipal InvestigatorShirley Ryan AbilityLab
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My child has CP due to premature birth complications.I have open sores on my legs that haven't healed.I do not have blood clots or unstable heart conditions.My child with CP hasn't had hippotherapy in the last 6 months.I have severe joint stiffness, bone fractures, or weak bones in my legs.My child can reliably indicate when they feel pain, fear, or discomfort.My child has a slight curve in their spine.I can sit without help for at least 10 seconds.My bones grow unevenly.My child is between 4 and 12 years old and hasn't had Botulinum toxin treatment or surgeries like selective dorsal rhizotomy in the past year.
Research Study Groups:
This trial has the following groups:- Group 1: Robotic hippotherapy
- Group 2: Conventional physical therapy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Do I meet the preconditions for this trial?
"To take part, potential participants should have been diagnosed with childhood behavior disorder and be between 4 to 12 years of age. Currently, 44 candidates are being sought for the trial."
Answered by AI
Is there an age cut-off for applicants to this research program?
"The terms of admission for this experiment necessitate that participants are between 4 and 12 years old. Of the 49 trials, 37 cater to individuals below the age of majority while the remaining focus on those above retirement age."
Answered by AI
Are there any vacancies for individuals to join this research project?
"Affirmative. According to clinicaltrials.gov, this medical study is presently recruiting individuals for participation. Initially posted on November 1st 2022 and last modified April 7th 2023, the trial seeks 44 patients from a solitary site."
Answered by AI
What is the total cohort size of this investigation?
"Affirmative. According to information on clinicaltrials.gov, this research is currently accepting participants. It was first announced November 1st 2022 and most recently edited April 7th 2023; 44 people are sought from one location for participation in the trial."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger